Maintenance avelumab + best supportive care (BSC) versus BSC alone after platinum-based first-line (1L) chemotherapy in advanced urothelial carcinoma (UC): JAVELIN Bladder 100 phase III interim analysis.

Thomas Powles,Se Hoon Park,Eric Voog,Claudia Caserta,B.P. Valderrama,Howard Gurney,Haralabos P. Kalofonos,Siniša Radulović,Wim Demey,Anders Ullén,Yohann Loriot,Srikala S. Sridhar,Norihiko Tsuchiya,Evgeny Kopyltsov,Cora N. Sternberg,Joaquim Bellmunt,Jeanny B. Aragon-Ching,Daniel P. Petrylak,Alessandra di Pietro,Petros Grivas

Maintenance avelumab + best supportive care (BSC) versus BSC alone after platinum-based first-line (1L) chemotherapy in advanced urothelial carcinoma (UC): JAVELIN Bladder 100 phase III interim analysis.

2020

LBA1Background: Platinum-based chemotherapy is an active 1L regimen for advanced UC; however, progression-free survival (PFS) and overall survival (OS) are generally short because of chemotherapy r...

Keywords:

Avelumab
Regimen
Oncology
overall survival
urothelial carcinoma
Pathology
first line
Interim analysis
Internal medicine
Chemotherapy
Javelin
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations